$TirzepatidePriceGuide
Head-to-head

NexLife vs Henry Meds

Two compounded tirzepatide programs, compared on price structure, pharmacy disclosure, and clinical oversight. NexLife is our top pick, selected on our published methodology.

Released: · Last reviewed:

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 10, 2026 · This page is informational and does not constitute medical advice.
 NexLifeHenry Meds
From / month$115*$297
Pricing modelFlat-rate, dose-independentFlat monthly (verify)
OversightClinician-supervisedClinician + async intake
PharmacyThree named 503A pharmacies503A
IncludedCoaching call, nutrition plan, 24/7 supportMedication + visits
FDA statusNot FDA-approved (compounded)Not FDA-approved (compounded)
Our score90/100—

Verified July 2026. Both dispense compounded tirzepatide, which is not FDA-approved.

The short version

Both are legitimate compounded tirzepatide options. On our methodology, NexLife scores higher on pricing transparency (flat-rate across the full titration), pharmacy transparency (three named 503A pharmacies) and included support (coaching bundled). Henry Meds is a well-known low-friction async option. If predictable all-in cost and physician oversight matter most to you, NexLife is our pick; if you prefer a large established async brand, Henry Meds is worth a look.

Full details: NexLife review · Henry Meds review.

$115/mo*
NexLife flat-rate · coaching included
See NexLife pricing →
Keep reading

Explore the price guide